Fresenius Medical Care (FME) Receives Average Recommendation of “Buy” from Analysts

Fresenius Medical Care (ETR:FME) has been assigned an average recommendation of “Buy” from the twenty-one analysts that are covering the stock, Marketbeat Ratings reports. Ten investment analysts have rated the stock with a hold recommendation and eleven have given a buy recommendation to the company. The average 1-year price target among brokers that have updated their coverage on the stock in the last year is €92.72 ($114.47).

A number of brokerages have recently issued reports on FME. Commerzbank set a €87.00 ($107.41) price objective on shares of Fresenius Medical Care and gave the stock a “neutral” rating in a research report on Wednesday, January 10th. Deutsche Bank set a €83.00 ($102.47) price objective on shares of Fresenius Medical Care and gave the stock a “neutral” rating in a research report on Monday, January 22nd. JPMorgan Chase set a €96.10 ($118.64) price objective on shares of Fresenius Medical Care and gave the stock a “buy” rating in a research report on Wednesday, March 28th. Citigroup set a €92.00 ($113.58) price objective on shares of Fresenius Medical Care and gave the stock a “buy” rating in a research report on Monday, February 12th. Finally, DZ Bank set a €107.00 ($132.10) price objective on shares of Fresenius Medical Care and gave the stock a “buy” rating in a research report on Wednesday, January 31st.

Shares of ETR:FME remained flat at $€82.98 ($102.44) during trading hours on Wednesday. Fresenius Medical Care has a 1 year low of €75.53 ($93.25) and a 1 year high of €93.82 ($115.83).

TRADEMARK VIOLATION NOTICE: This story was first posted by WKRB News and is the property of of WKRB News. If you are accessing this story on another website, it was illegally stolen and republished in violation of United States and international trademark and copyright law. The legal version of this story can be accessed at https://www.wkrb13.com/2018/04/02/fresenius-medical-care-fme-receives-average-recommendation-of-buy-from-analysts.html.

Fresenius Medical Care Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the U.S.

Analyst Recommendations for Fresenius Medical Care (ETR:FME)

Receive News & Ratings for Fresenius Medical Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply